Inflammation in Cardiovascular Disease
- 26 May 1998
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 97 (20), 2000-2002
- https://doi.org/10.1161/01.cir.97.20.2000
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the ElderlyArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Elaboration of Type-1 Plasminogen Activator Inhibitor From AdipocytesCirculation, 1996
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- Fibrinogen and risk of cardiovascular disease. The Framingham StudyJAMA, 1987
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Raised C-reactive protein levels in serum from smokersClinica Chimica Acta; International Journal of Clinical Chemistry, 1985
- C-REACTIVE PROTEIN FIFTY YEARS ONThe Lancet, 1981
- The Concentration of C-Reactive Protein in Sera from Healthy IndividualsScandinavian Journal of Clinical and Laboratory Investigation, 1972